Adial Pharmaceuticals Announces Research Collaboration with UC San Diego to Advance Purnovate’s Adenosine Compounds as Potential Treatments for Inflammatory Diseases & Disorders
The research collaboration agreement will further evaluate the Company’s proprietary adenosine analogs as a potential treatment for inflammatory diseases.